WCLC 2025 - Posters & ePosters-PT1.06.01 ERBB2 (HER2) Fusions in Lung Cancer Are Targetable by Anti-HER2 Small Molecules and Antibody-Drug Conjugates

PT1.06.01 ERBB2 (HER2) Fusions in Lung Cancer Are Targetable by Anti-HER2 Small Molecules and Antibody-Drug Conjugates

Asset Subtitle

Marc Ladanyi

Meta Tag

Speaker Marc Ladanyi

Topic Pathology and Biomarkers